SCHEMBL2137634

SCHEMBL2137634

CCCCCCCCc1ccc(C#Cc2c3ccccc3c(C#Cc3ccc(CCCCCCCC)cc3)c3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.51
TSHR P16473 1/20 0.51
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
HTR2A P28223 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
SHBG P04278 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
HSPD1 P10809 1/20 0.47
ADRB3 P13945 1/20 0.47
HTR2C P28335 1/20 0.47
HSPE1 P61604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11023790 1.00 HSD17B10 (0.51) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL11023863 1.00 HSD17B10 (0.51) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL11028593 0.93 FFAR1 (0.46) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL716818 0.90 HSD17B10 (0.42) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL30762968 0.88 HSD17B10 (0.59) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL5202384 0.88 HSD17B10 (0.59) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL2837648 0.86 FFAR1 (0.57) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL4585249 0.86 HSD17B10 (0.44) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL9330376 0.86 HSD17B10 (0.65) HSD17B10TSHRESR1ADRA2AADORA3
SCHEMBL9329731 0.86 HSD17B10 (0.65) HSD17B10TSHRESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0084599-B1 9,10-BIS -ALKYLPHENYLETHYNYL-ANTHRACENES AND CHEMILUMINESCENT COMPOSITIONS AMERICAN CYANAMID COMPANY (US) 1985-05-15 EP claimed
US-4401585-A FLUORESER REACTING WITH PEROXIDE TO CHEMILUMINESCE AMERICAN CYANAMID COMPANY (US) 1983-08-30 US claimed
EP-0084599-A1 9,10-Bis -alkylphenylethynyl-anthracenes and chemiluminescent compositions AMERICAN CYANAMID COMPANY (US) 1983-08-03 EP claimed
US-7906225-B2 Synthesis of phenyl-substituted fluoranthenes by a diesel-alder and the use thereof BASF AKTIENGESELLSCHAFT (DE) 2011-03-15 US disclosed
EP-1673322-B1 SYNTHESIS OF PHENYL-SUBSTITUTED FLUORANTHENES BY A DIESEL-ALDER REACTION AND THE USE THEREOF BASF SE (DE) 2008-04-16 EP disclosed
US-20070069198-A1 Synthesis of phenyl-substituted fluoranthenes by a diesel-alder reaction and the use thereof BASF AKTIENGESSLLSCHAFT (DE) 2007-03-29 US disclosed
EP-1673322-A1 SYNTHESIS OF PHENYL-SUBSTITUTED FLUORANTHENES BY A DIESEL-ALDER REACTION AND THE USE THEREOF BASF Aktiengesellschaft (DE) 2006-06-28 EP disclosed
WO-2005033051-A1 SYNTHESIS OF PHENYL-SUBSTITUTED FLUORANTHENES BY A DIESEL-ALDER REACTION AND THE USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2005-04-14 WO disclosed
EP-0084599-B1 9,10-BIS -ALKYLPHENYLETHYNYL-ANTHRACENES AND CHEMILUMINESCENT COMPOSITIONS AMERICAN CYANAMID COMPANY (US) 1985-05-15 EP disclosed
US-4401585-A FLUORESER REACTING WITH PEROXIDE TO CHEMILUMINESCE AMERICAN CYANAMID COMPANY (US) 1983-08-30 US disclosed
EP-0084599-A1 9,10-Bis -alkylphenylethynyl-anthracenes and chemiluminescent compositions AMERICAN CYANAMID COMPANY (US) 1983-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070069198-A1 Synthesis of phenyl-substituted fluoranthenes by a diesel-alder reaction and the use thereof OXER1, DRD3, DRD4 HSD17B10 820/4885TSHR 2118/4885ESR1 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.